Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health is seeking a single-source U24 cooperative agreement to continue the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Resource Center. The work will expand the human cardiovascular tissue biorepository, strengthen the data commons for sharing and AI tools, coordinate consortium research activities, and make CaRe-T1D resources available to the broader research community. This is a peer-reviewed, clinical-trial-not-allowed funding opportunity tied to the Special Diabetes Program, with a five-year project period described in the announcement. The University of Florida is the sole eligible applicant, with a funding commitment of $2 million for FY 2027, annual direct costs capped at $1.5 million, an earliest submission date of August 30, 2026, and an expiration date of October 1, 2026.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Only the following applicant is eligible to apply for this single source funding: University of Florida. Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.